
Fecal microbiota transplantation as an effective initial therapy for pancreatitis complicated with severe Clostridium difficile infection: A case report
Author(s) -
Yang Hu,
Haiying Xiao,
Cong He,
ghua Lv,
Liang Zhu
Publication year - 2019
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v7.i17.2597
Subject(s) - medicine , clostridium difficile , acute pancreatitis , colonoscopy , pseudomembranous colitis , pancreatitis , diarrhea , fecal bacteriotherapy , complication , metronidazole , gastroenterology , surgery , antibiotics , microbiology and biotechnology , biology , colorectal cancer , cancer
Moderately severe acute pancreatitis (MSAP) is a critical form of acute pancreatitis that is related with high morbidity and mortality. Severe Clostridium difficile infection (sCDI) is a serious and rare nosocomial diarrheal complication, especially in MSAP patients. Fecal microbiota transplantation (FMT) is a highly effective treatment for refractory and recurrent CDI (rCDI). However, knowledge regarding the initial use of FMT in patients suffering from sCDI is limited.